In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: NebuPent (Astellas); Pentacarinat (Sanofi-Aventis); Pentam 300 (Astellas)
- INDICATIONS: Pneumocystis jiroveci infection, trypanosomiasis, leishmaniasis
- CLASS: Antimicrobial, Antiprotozoal
- HALF-LIFE: 9.1–13.2 hours (intramuscular); 6.5 hours (intravenous)
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adefovir, Aminoglycosides, Amiodarone, Amisulpride, Amitriptyline, Amphotericin B, Cisplatin, Droperidol, Erythromycin, Foscarnet, Insulin Aspart, Insulin Degludec, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Ivabradine, Levomepromazine, Moxifloxacin, Phenothiazines, Saquinavir, Sparfloxacin, Sulpiride / levosulpiride, Tricyclic antidepressants, Trifluoperazine, Vancomycin
- See adverse reactions attributed to class:
The rate of adverse side effects is increased in patients with AIDS.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
